TRIO-US, Inc.

We are hiring a Clinical Research Associate to join the team at TRIO-US. Full-time position, home-based in the US, with 25% domestic travel. Ideal candidate has oncology, Phase I study, and research site work experience. Must be detail-oriented, organized, and an effective communicator. Do you know someone who fits the bill?

We're #hiring a new Clinical Research Coordinator in Las Vegas, Nevada. Apply today or share this post with your network.

?? Regulatory Update: Expanding Cancer Clinical Trial Eligibility ? The FDA has released three draft guides aimed at increasing diversity and participation in oncology clinical trials by broadening eligibility criteria. These new guidelines focus on laboratory values, washout periods and concomitant medications, and patient performance status. This initiative is part of a broader effort to ensure that clinical trials are more inclusive and reflective of the diverse patient populations affected by cancer. ? Key Highlights: ? ??Laboratory Values: Customizing criteria to match the investigational drug, ensuring unnecessary exclusions are avoided. ??Washout Periods and Concomitant Medications: Justifying time-based washout periods and allowing more patients, especially older ones on multiple medications, to participate. ??Performance Status: Expanding eligibility to include lower-performing patients, enhancing trial diversity and the relevance of results. ? For more details on these important updates, read the original article: https://lnkd.in/ei3MZpzY ? #CancerResearch #ClinicalTrials #FDA #OncologyInnovation

Like each of the TRIO team members across the world, I am grateful, continuously inspired and honored to be part of Dr. Dennis Slamon's adventure to transform cancer treatment. Congratulations for being awarded by the National Foundation for Cancer Research with the 2024 Szent-Gy?rgyi Prize for Progress in Cancer Research, for groundbreaking research discoveries that helped to shape the field of precision medicine for breast cancer patients. -Catherine Marle, CEO, TRIO More about the award: https://lnkd.in/gy_4Mgur

Excitement is mounting for the upcoming #ASCO24 conference, just one week away! Eagerly anticipating the chance to reconnect with peers and explore the latest advancements in the field of #oncology. Stay tuned for valuable insights on cutting-edge #cancerresearch.

Excitement is mounting for the upcoming #ASCO24 conference as we now just two weeks out! Eagerly anticipating the chance to reconnect with peers and delve into the latest advances in the field of #oncology. Stay tuned for valuable insights on cutting-edge #cancerresearch.

Excitement is continuing to build for #ASCO24, 3 weeks to go! Looking forward to reconnecting with colleagues and diving into the latest breakthroughs in #oncology. Stay tuned for valuable insights on cutting-edge #cancerresearch.

Excitement is building for #ASCO24, just a month away! Looking forward to reconnecting with colleagues and diving into the latest breakthroughs in #oncology. Stay tuned for valuable insights on cutting-edge #cancerresearch.

TRIO's NATALEE Trial results were live on the Today show earlier today. NBC News medical contributor Dr. Natalie Azar joined to help break down the study for viewers. Watch at the link:

We wanted to thank everyone who came out to our Women in Oncology event on Wed. March 20th. It was great seeing women from all over the Greater LA area get together to empower one another. Special shoutout to Michele Atlan from National Breast Cancer Coalition for giving an amazing talk on how patient advocacy can influence research. Be sure to check out our website for future events!